Thymidine Kinase Activity
The Thymidine Kinase Activity test is an in vitro diagnostic device that measures thymidine kinase activity (TKa) in patient samples to aid in monitoring disease progression in breast cancer patients. Elevated thymidine kinase activity is a marker associated with active cell proliferation and tumor burden. Classified as FDA Class 2 under regulation 866.6010, it requires 510(k) clearance in the Immunology specialty. The device is not an implant and not life-sustaining.
Research product code QTE in seconds
The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.
Free to try · every answer cites its records
Basic Information
- Product Code
- QTE
- Device Class
- FDA class 2
- Regulation Number
- 866.6010
- Medical Specialty
- Immunology
- Review Panel
- IM
- Submission Type
- 1
Device Characteristics
Definition
In vitro test to measure thymidine kinase activity (TKa) to aid in monitoring disease progression of breast cancer patients.
510(k) Clearance History
Related 510(k) Clearances
This FDA classification is associated with 1 510(k) clearance via K numbers.
| K Number | Device Name | Decision Date | Decision | Applicant |
|---|---|---|---|---|
| K202852 | DiviTum TKa | Jul 29, 2022 | Substantially Equivalent | Biovica International AB |
FEI Numbers
This FDA classification entry is associated with 1 FEI number. Click on an entry to view related FDA registrations.
Registration Numbers
This FDA classification entry is associated with 1 registration number. Click on an entry to view related FDA registrations.